Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2025)
Carlsmed's (CARL) quarterly Net Equity Issued and Repurchased came in at $11.9 million in Q1 2025, up 36218.18% quarter-over-quarter from -$33000.0 in Q4 2024.
Powered by 
Analysis
Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
Carlsmed (CARL) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $11.9 million the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $11.9 million; the trailing twelve-month figure through Dec 2025 stood at $11.9 million (changed N/A YoY), and the FY2025 full-year result was $11.9 million, down 77.19% from the prior year.
- Net Equity Issued and Repurchased grew to $11.9 million in Q1 2025 per CARL's latest filing, from -$33000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $14.0 million in Q3 2024 and bottomed at -$132000.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 29.31 Mn |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 11.92 Mn |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | -132,000.00 |